Both the key network target identification and functional module analysis revealed that the inflammation-immune mediated by PI3K/AKT/NF-kB signal may be associated with the pharmacological properties of CRT to ameliorate DKD. This evidence concerns the gene NFKB1 and diabetic kidney disease.